Evaluation of a Commercial Culture-Free Neutralization Antibody Detection Kit for Severe Acute Respiratory Syndrome-Related Coronavirus-2 and Comparison With an Antireceptor-Binding Domain Enzyme-Linked Immunosorbent Assay

BACKGROUND: Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) surrogate neutralization assays that obviate the need for viral culture offer substantial advantages regarding throughput and cost. The cPass SARS-CoV-2 Neutralization Antibody Detection Kit (GenScript) is the first suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Papenburg, Jesse, Cheng, Matthew P, Corsini, Rachel, Caya, Chelsea, Mendoza, Emelissa, Manguiat, Kathy, Lindsay, L Robbin, Wood, Heidi, Drebot, Michael A, Dibernardo, Antonia, Zaharatos, Gerasimos, Bazin, Reneé, Gasser, Romain, Benlarbi, Mehdi, Gendron-Lepage, Gabrielle, Beaudoin-Bussières, Guillaume, Prévost, Jérémie, Finzi, Andrés, Ndao, Momar, Yansouni, Cedric P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135688/
https://www.ncbi.nlm.nih.gov/pubmed/34136587
http://dx.doi.org/10.1093/ofid/ofab220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135688/
https://www.ncbi.nlm.nih.gov/pubmed/34136587
http://dx.doi.org/10.1093/ofid/ofab220

Ejemplares similares